Skip to main content
Steven Kahn, MD, Endocrinology, Seattle, WA

StevenEmanuelKahnMD

Endocrinology Seattle, WA

Diabetes, Lipid Metabolism, Obesity

Professor, Medicine, University of Washington School of Medicine

Dr. Kahn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kahn's full profile

Already have an account?

  • Office

    1660 S Columbian Way
    Seattle, WA 98108
    Phone+1 206-277-5515
    Fax+1 206-764-2693

Education & Training

  • University of Washington
    University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1988
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkResidency, Internal Medicine, 1983 - 1985
  • University of Cape Town Faculty of Medicine
    University of Cape Town Faculty of MedicineClass of 1978

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1986 - 2025
  • PA State Medical License
    PA State Medical License 1984 - 1988
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member Association of American Physicians, 2009
  • Elected Member The American Society for Clinical Investigation, 2000

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Call for Improved Reporting of Human Islet Characteristics in Research Articles  
    Steven E Kahn, Kevan C Herold, Maureen Gannon, Diabetologia
  • Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults with Type 2 Diabetes and High Cardiovascular and Renal Risk  
    Steven E Kahn, John H Alexander, Robert D Toto, Darren K McGuire, JAMA
  • Genetic Ancestry Markers and Difference in A1c Between African-American and White in the Diabetes Prevention Program  
    Steven Kahn, William C Knowler, Kieren J Mather, Jose C Florez, The Journal of Clinical Endocrinology and Metabolism

Lectures

  • Novel Approaches to Restore Beta Cell Function in Prediabetes and Type 2 Diabetes 
    Seattle, WA - 6/14/2014

Press Mentions

  • New SELECT Trial Analysis with Semaglutide 2.4 Mg Showed a Significant Reduction in Hospital Admissions in Adults with Known Heart Disease and Obesity or Overweight
    New SELECT Trial Analysis with Semaglutide 2.4 Mg Showed a Significant Reduction in Hospital Admissions in Adults with Known Heart Disease and Obesity or OverweightNovember 3rd, 2024
  • Tirzepatide Leads to Long-Term Glucose Control
    Tirzepatide Leads to Long-Term Glucose ControlSeptember 25th, 2024
  • Blood Sugar Meds Against Type 2 Diabetes
    Blood Sugar Meds Against Type 2 DiabetesJuly 1st, 2021
  • Join now to see all

Grant Support

  • Pathogenesis And Impact Of Islet AmyloidVeterans Affairs2011–2012
  • Diabetes Endocrinology Research CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2011–2012
  • Diabetes Prevention Program Outcomes Study - Phase 2National Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
  • Optimizing Recovery And Preservation Of Endogenous Insulin SecretionNational Institute Of Diabetes And Digestive And Kidney Diseases2011
  • Mechanisms Of Islet AmyloidogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
  • Study Of Health Outcomes Of Weight Loss: Look Ahead-Action For Health In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
  • Post-Ddp Follow-Up StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2008
  • Impact Of Short-Term Hyperglycemia On Cell Function And Insulin SensitivityNational Center For Research Resources2006–2007
  • Study Of Health Outcomes Of Weight-Loss (SHOW)National Institute Of Diabetes And Digestive And Kidney Diseases2006
  • Study Of Health Outcomes Of Weight-Loss (SHOW)National Institute Of Diabetes And Digestive And Kidney Diseases2001–2005
  • Islet Function In Type 2 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
  • Clinical Center For Look Ahead: Health In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
  • NIDDM Primary Prevention Trial (Dpp-2)National Institute Of Diabetes And Digestive And Kidney Diseases1997–2002
  • Dietary Fat On Insulin Sensitivity &Islet Beta Cell FunctionNational Center For Research Resources2000
  • Role Of Dietary Fat On Insulin Sensitivity &Islet Beta Cell FunctionNational Center For Research Resources1999–2000
  • European Association For Study Of Diabetes International Training CouNational Center For Research Resources1999–2000
  • Mechanism Of Islet Amyloid FormationNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2000
  • NIDDM Primary Prevention Trial (Dpp 2)National Institute Of Diabetes And Digestive And Kidney Diseases1998
  • NIDDM Primary Prevention Trial (Dpt-2)National Institute Of Diabetes And Digestive And Kidney Diseases1994–1997
  • Genetics Of NIDDMNational Center For Research Resources1996

Professional Memberships